Compared with its use for chronic pain, reliable evidence to support the use of cannabis to treat anxiety is lacking and available data are “conflicting.” To bring clarity to the issue, researchers conducted a retrospective database study of Canadian medical cannabis patients.
This cross-sectional geospatial analysis was conducted by investigators at the University of Chicago using the social vulnerability index data from the CDC and data from SAMHSA.
Baseline cannabinoid use is associated with higher sedation use during endoscopy with endoscopist-directed conscious sedation.
Researchers examined meaningful within-patient changes in WOMAC using data from 3 trials that included patients with moderate to severe hip and knee osteoarthritis.
Sandra Springer, MD, and Laura Marks, MD, PhD, highlight the need for a combined treatment approach for patients with drug-use associated infections.
The FDA urges consumers to buy prescription drugs, such as Adderall, from state-licensed US pharmacies or physicians located in the US.
Female trauma patients have longer delays in trauma care and an increased likelihood of discharge to long-term care facilities compared with male trauma patients.
Temporomandibular disorder (TMD)-induced pain and menopausal symptoms are correlated.
The growth in the number of clinicians with waivers to prescribe buprenorphine slowed during the pandemic, and support and mentorship are needed to facilitate obtaining a waiver.
Individuals with OUD and polysubstance use are less likely to initiate buprenorphine and naltrexone than individuals with OUD without polysubstance use.